Sec. 704. Stopping the spread of COVID–19 and other infectious diseases through evidence-based vaccine awareness
1,055 words·~5 min read·
/bill/116/hr/925/eah/section-704A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Public Health Service Act is amended by striking section 313 of such Act ( 42 U.S.C. 245 ) and inserting the following: The Secretary, acting through the Director of the Centers for Disease Control and Prevention and in coordination with other offices and agencies, as appropriate, shall award competitive grants or contracts to one or more public or private entities to carry out a national, evidence-based campaign for increasing rates of vaccination across all ages, as applicable, particularly in communities with low rates of vaccination, to reduce and eliminate vaccine-preventable diseases by— increasing awareness and knowledge of the safety and effectiveness of vaccines approved or authorized by the Food and Drug Administration for the prevention and control of diseases, including COVID–19; combating misinformation about vaccines; and disseminating scientific and evidence-based vaccine-related information.
In carrying out the campaign under this section, the Secretary shall consult with appropriate public health and medical experts, including the National Academy of Medicine and medical and public health associations and nonprofit organizations, in the development, implementation, and evaluation of the campaign under this section. The campaign under this section shall— be a nationwide, evidence-based media and public engagement initiative; include the development of resources for communities with low rates of vaccination, including culturally and linguistically appropriate resources, as applicable; include the dissemination of vaccine information and communication resources to public health departments, health care providers, and health care facilities, including such providers and facilities that provide prenatal and pediatric care; be complementary to, and coordinated with, any other Federal, State, local, or Tribal efforts; assess the effectiveness of communication strategies to increase rates of vaccination; and not be used for partisan political purposes, or to express advocacy in support of or to defeat any clearly identified candidate, clearly identified ballot initiative, or clearly identified legislative or regulatory proposal.
The campaign under this section may— include the use of television, radio, the internet, and other media and telecommunications technologies; include the use of in-person activities; be focused and directed to address specific needs of communities and populations with low rates of vaccination; and include the dissemination of scientific and evidence-based vaccine-related information, such as— advancements in evidence-based research related to diseases that may be prevented by vaccines and vaccine development; information on vaccinations for individuals and communities, including individuals for whom vaccines are not recommended by the Advisory Committee for Immunization Practices, and the effects of low vaccination rates within a community on such individuals; information on diseases that may be prevented by vaccines; and information on vaccine safety and the systems in place to monitor vaccine safety.
The Secretary shall— establish benchmarks and metrics to quantitatively measure and evaluate the campaign under this section; conduct qualitative assessments regarding the campaign under this section; and prepare and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate an evaluation of the campaign under this section. Funds made available to carry out this section shall be used to supplement and not supplant other Federal, State, local, and Tribal public funds provided for activities described in this section.
There is authorized to be appropriated to carry out this section $200,000,000 for the period of fiscal years 2021 through 2025. . Section 317 of the Public Health Service Act ( 42 U.S.C. 247b ) is amended— in subsection (k)— in paragraph (1)— in subparagraph (C), by striking ; and at the end and inserting a semicolon; in subparagraph (D), by striking the period at the end and inserting a semicolon; and by adding at the end the following: planning, implementation, and evaluation of activities to address vaccine-preventable diseases, including activities— to identify communities at high risk of outbreaks related to vaccine-preventable diseases, including through improved data collection and analysis; to pilot innovative approaches to improve vaccination rates in communities and among populations with low rates of vaccination; to reduce barriers to accessing vaccines and evidence-based information about the health effects of vaccines; to partner with community organizations and health care providers to develop and deliver evidence-based, culturally and linguistically appropriate interventions to increase vaccination rates; to improve delivery of evidence-based vaccine-related information to parents and others; and to improve the ability of State, local, Tribal, and territorial public health departments to engage communities at high risk for outbreaks related to vaccine-preventable diseases, including, as appropriate, with local educational agencies (as defined in section 8101 of the Elementary and Secondary Education Act of 1965); and research related to strategies for improving awareness of scientific and evidence-based vaccine-related information, including for communities with low rates of vaccination, in order to understand barriers to vaccination, improve vaccination rates, and assess the public health outcomes of such strategies. ; and by adding at the end the following:
In addition to amounts authorized to be appropriated by subsection
(j)to carry out this subsection, there is authorized to be appropriated to carry out this subsection $750,000,000 for the period of fiscal years 2021 through 2025. ; and by adding at the end the following: The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall expand and enhance, and, as appropriate, establish and improve, programs and conduct activities to collect, monitor, and analyze vaccination coverage data to assess levels of protection from vaccine-preventable diseases including COVID–19, including by— assessing factors contributing to underutilization of vaccines and variations of such factors; and identifying communities at high risk of outbreaks associated with vaccine-preventable diseases. There is authorized to be appropriated to carry out this section $50,000,000 for the period of fiscal years 2021 through 2025. . Section 330(d)(1) of the Public Health Service Act ( 42 U.S.C. 254b(d)(1) ) is amended— in subparagraph (F), by striking and at the end; in subparagraph (G), by striking the period at the end and inserting ; and ; and by adding at the end the following: improving access to recommended immunizations. . The National Vaccine Advisory Committee established under section 2105 of the Public Health Service Act ( 42 U.S.C. 300aa–5 ) shall, as appropriate, update the report entitled, Assessing the State of Vaccine Confidence in the United States: Recommendations from the National Vaccine Advisory Committee , approved by the National Vaccine Advisory Committee on June 10, 2015, with respect to factors affecting childhood vaccination.
Connectionstraces to 3
1 reference not yet in our index
- 42 USC 300aa–5
Citation graph
cites case law
Sec. 704
Stopping the spread of COVID–19 and other infectious diseases through evidence-based vaccine awareness
Cite42 USC 300aa–5
Cites 4Cited by 0 across 0 sources